Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 4, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 6, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-452143
Filed / recorded
Nov 6, 2026, 10:35 PM UTC
Added to OQRO
Nov 6, 2026, 10:36 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CRISPR Therapeutics AG
Issuer CIK
1674416
Ticker
CRSP
Reporting person
Sivakesava Sakhamuri
Relationship
Officer
Officer title
Chief Technical Officer
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Nov 4, 2026
Transaction code
A
Shares / units
40,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
40,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
This restricted stock unit award was granted on November 4, 2026 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on November 2, 2027, (ii) one quarter of the shares vesting on November 2, 2028, (iii) one quarter of the shares vesting on November 2, 2029, and (iv) one quarter of the shares vesting on November 2, 2030.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.